Skip to content

PRECICE® Bone Transport System BT10-80D320-7Recalls & reported problems

Nuvasive Specialized Orthopedics, Inc. · Antegrade Femur Trochanter 10° Bend, 10.0mm x 320mm, 7/8cm ST · Class 2 · Implant

All models of PRECICE Bone Transport System (561)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
2

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00887517980205), received between Dec 22, 2025 and Dec 22, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Failure to Advance” (1 report).

2 FDA recall records name this device's identifier, 2 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Feb 12, 2021Class IIOpen, Classified

    Due to complaints of adverse events potentially related to biological safety. The complaints included report of pain and bony abnormalities at the interface between the telescoping nail segments.

    Z-1324-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  2. Feb 12, 2021Class IIOpen, Classified

    Due to complaints of adverse events potentially related to biological safety. The complaints included report of pain and bony abnormalities at the interface between the telescoping nail segments.

    Z-1323-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Failure to Advance1

Patient problems

  • Failure of Implant1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 22, 2025Failure to Advance; Failure to Advance

    ON (B)(6) 2025, A PATIENT UNDERWENT ANKLE ARTHRODESIS, AND A BONE TRANSPORT FEMUR NAIL, PREVIOUSLY PLANNED BY THE SURGEON, WAS IMPLANTED. DURING POSTOPERATIVE FOLLOW-UP, IT WAS OBSERVED THAT THE IMPLANT WAS NOT FUNCTIONING. A NEW SURGERY WAS SCHEDULED FOR (B)(6) 2025. THE IMPLANT WAS CHECKED BOTH INSIDE AND OUTSIDE THE PATIENT USING A FAST DISTRACTOR AND WITH ERC (ELECTROMAGNETIC RESONANCE IMAGING), AND THE MECHANISM WAS FOUND TO BE NON-FUNCTIONAL. THEREFORE, IT WAS DECIDED TO REPLACE IT WITH A NEW ONE, WHICH ULTIMATELY DID FUNCTION. THE DELAY IN REPORTING THE INCIDENT WAS DUE TO THE HOSPITAL FIRST DECONTAMINATING THE NAIL, AND THEN SEVERAL INTERNAL COMMUNICATION ERRORS (AN INTERNAL NON-CONFORMITY REPORT HAS BEEN FILED REGARDING THIS ISSUE, AND TRAINING WILL BE PROVIDED).

    Patient problems: Failure of Implant; No Clinical Signs, Symptoms or Conditions

    MAUDE report 23865365 ↗

Other Rod, Fixation, Intramedullary And Accessories devices

All Rod, Fixation, Intramedullary And Accessories devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page